Logo image
New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis
Journal article   Open access   Peer reviewed

New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis

Florian Rambow, Bastien Job, Valérie Petit, Franck Gesbert, Véronique Delmas, Hannah Seberg, Guillaume Meurice, Eric Van Otterloo, Philippe Dessen, Caroline Robert, …
Cell reports (Cambridge), Vol.13(4), pp.840-853
10/27/2015
DOI: 10.1016/j.celrep.2015.09.037
PMCID: PMC5970542
PMID: 26489459
url
https://doi.org/10.1016/j.celrep.2015.09.037View
Published (Version of record) Open Access

Abstract

Molecular signatures specific to particular tumor types are required to design treatments for resistant tumors. However, it remains unclear whether tumors and corresponding cell lines used for drug development share such signatures. We developed similarity core analysis (SCA), a universal and unsupervised computational framework for extracting core molecular features common to tumors and cell lines. We applied SCA to mRNA/miRNA expression data from various sources, comparing melanoma cell lines and metastases. The signature obtained was associated with phenotypic characteristics in vitro, and the core genes CAPN3 and TRIM63 were implicated in melanoma cell migration/invasion. About 90% of the melanoma signature genes belong to an intrinsic network of transcription factors governing neural development (TFAP2A, DLX2, ALX1, MITF, PAX3, SOX10, LEF1, and GAS7) and miRNAs (211-5p, 221-3p, and 10a-5p). The SCA signature effectively discriminated between two subpopulations of melanoma patients differing in overall survival, and classified MEKi/BRAFi-resistant and -sensitive melanoma cell lines. [Display omitted] •Similarity core analysis (SCA) is a bioinformatics tool for analyzing expression data•SCA generates specific transcriptome-miRnome signatures for any tumor type•SCA clusters aggressive and non-aggressive tumors and cell lines•Molecular signatures reveal a lineage-specific regulatory network for melanoma Cancer cell lines are at the forefront of drug discovery but are often limited in representing the tumor of origin due to the artificial culture conditions. Rambow et al. develop a computational approach for identifying tumor cell lineage expression cores. These core genes reveal relevant molecular dependencies linking aggressiveness, patient survival, and drug sensitivity.
Ewing sarcoma liver transcriptome survival neuroblastoma melanoma lung ovary glioblastoma phenotype switching colon miRNA breast

Details

Logo image